CA2361364A1 — Dalda analogs and their use
Assigned to Cornell Research Foundation Inc · Expires 2000-09-21 · 26y expired
What this patent protects
Compounds of formula (I) are disclosed and claimed in the present applicatio n, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, particularly in the management of pain, and more particularly i…
USPTO Abstract
Compounds of formula (I) are disclosed and claimed in the present applicatio n, as well as their pharmaceutically acceptable salts, pharmaceutical compositions comprising the novel compounds and their use in therapy, particularly in the management of pain, and more particularly in the management of pain during labor.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.